RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of PRQR
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Big movements in ProQR Therapeutics N.V. stock price on Thursday moving 10.76% between high and low
(Updated on Mar 28, 2024)

Buy or Hold candidate since Mar 12, 2024 Gain 11.70% PDF

The ProQR Therapeutics N.V. stock price fell by -3.79% on the last day (Thursday, 28th Mar 2024) from $2.38 to $2.29. During the last trading day the stock fluctuated 10.76% from a day low at $2.23 to a day high of $2.47. The price has fallen in 6 of the last 10 days and is down by -1.3% for this period. Volume has increased on the last day by 67 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 106 thousand shares were bought and sold for approximately $243.28 thousand.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 7.68% during the next 3 months and, with a 90% probability hold a price between $2.10 and $3.26 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

PRQR Signals & Forecast

The ProQR Therapeutics N.V. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $2.39. On a fall, the stock will find some support from the long-term average at approximately $2.15. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, March 15, 2024, and so far it has fallen -10.55%. Further fall is indicated until a new bottom pivot has been found. ProQR Therapeutics N.V. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for ProQR Therapeutics N.V. stock

On the downside, the stock finds support just below today's level from accumulated volume at $2.12 and $2.09. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, ProQR Therapeutics N.V. finds support just below today's level at $2.12. If this is broken, then the next support from accumulated volume will be at $2.09 and $1.94.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.240 between high and low, or 10.76%. For the last week, the stock has had daily average volatility of 6.14%.

Our recommended stop-loss: $2.18 (-4.80%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 9 days ago.)

Trading Expectations (PRQR) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect ProQR Therapeutics N.V. to open at $2.33, and during the day (based on 14 day Average True Range), to move between $2.12 and $2.46, which gives a possible trading interval of +/-$0.174 (+/-7.62%) up or down from last closing price. If ProQR Therapeutics N.V. takes out the full calculated possible swing range there will be an estimated 15.23% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.33 (1.75%) than the support at $2.12 (7.42%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is ProQR Therapeutics N.V. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for ProQR Therapeutics N.V. stock to perform well in the short-term.

Current score: 3.061 Buy Candidate Unchanged

Predicted Opening Price for ProQR Therapeutics N.V. of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$2.33 ( 1.75%) $2.29

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for PRQR

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.57 12.23 %
R2 2.48 8.23 %
R1 2.42 5.75 %
Current price: 2.29
Support S1 2.24 -2.25 %
S2 2.18 -4.73 %
S3 2.09 -8.73 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.85 24.46 %
R2 2.50 9.18 %
R1 2.33 1.75 %
Current price 2.29
Support S1 2.12 -7.42%
S2 2.09 -8.73%
S3 1.94 -15.28%

FAQ

What is the symbol for ProQR Therapeutics N.V. Stock and on which exchange is it traded?
The symbol for ProQR Therapeutics N.V. is PRQR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ProQR Therapeutics N.V. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for ProQR Therapeutics N.V. stock to perform well in the short-term.

How to buy ProQR Therapeutics N.V. Stock?
ProQR Therapeutics N.V. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ProQR Therapeutics N.V. Stock.

What's the current price of ProQR Therapeutics N.V. Stock?
As of the end of day on the 2024-03-28, the price of an ProQR Therapeutics N.V. (PRQR) share was $2.29.

What is the 52-week high and low for ProQR Therapeutics N.V. Stock?
The 52-week high for ProQR Therapeutics N.V. Stock is $3.29 and the 52-week low is $1.11.

What is the market capitalization of ProQR Therapeutics N.V. Stock?
As of the 2024-03-28, the market capitalization of ProQR Therapeutics N.V. is 193.961M.

When is the next earnings date for ProQR Therapeutics N.V.?
The upcoming earnings date for ProQR Therapeutics N.V. is May 21, 2024.
Click to get the best stock tips daily for free!

About ProQR Therapeutics N.V.

ProQR Therapeutics N.V. ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clinical trial to treat USH2A-mediated retinitis pigmentosa and usher syndrome. The company also engages in... PRQR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT